| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |